Published in Exp Dermatol on August 01, 2003
Alopecia: possible causes and treatments, particularly in captive nonhuman primates. Comp Med (2009) 2.20
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72
Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol (2003) 1.22
Hair loss and hypothalamic-pituitary-adrenocortical axis activity in captive rhesus macaques (Macaca mulatta). J Am Assoc Lab Anim Sci (2014) 0.91
Stress-induced neurogenic inflammation in murine skin skews dendritic cells towards maturation and migration: key role of intercellular adhesion molecule-1/leukocyte function-associated antigen interactions. Am J Pathol (2008) 0.88
Chronic restraint stress inhibits hair growth via substance P mediated by reactive oxygen species in mice. PLoS One (2013) 0.87
Resting no more: re-defining telogen, the maintenance stage of the hair growth cycle. Biol Rev Camb Philos Soc (2014) 0.81
Assessing significant (>30%) alopecia as a possible biomarker for stress in captive rhesus monkeys (Macaca mulatta). Am J Primatol (2016) 0.80
5-HT1A/1B receptors as targets for optimizing pigmentary responses in C57BL/6 mouse skin to stress. PLoS One (2014) 0.77
Investigating the stress attenuating potential of furosemide in immobilization and electric foot-shock stress models in mice. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.75
Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest (2002) 1.60
E-cadherin interactions are required for Langerhans cell differentiation. Eur J Immunol (2012) 1.45
Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology (2008) 1.23
Epidemiology of visceral mycoses in autopsy cases in Japan: comparison of the data from 1989, 1993, 1997, 2001, 2005 and 2007 in Annual of Pathological Autopsy Cases in Japan. Med Mycol J (2011) 1.12
Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES. Int Arch Allergy Immunol (2003) 1.07
Sebaceous carcinoma: an immunohistochemical reappraisal. Am J Dermatopathol (2011) 1.06
Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells. Biochem Biophys Res Commun (2003) 1.06
Wound healing involves induction of cyclooxygenase-2 expression in rat skin. Lab Invest (2002) 1.05
Ultrastructural evidence for thermal injury to pilosebaceous units during the treatment of acne using photopneumatic (PPX) therapy. J Cosmet Laser Ther (2008) 1.03
Effects of urocortin 2 and 3 on motor activity and food intake in rats. Peptides (2004) 1.03
Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris. J Invest Dermatol (2004) 1.01
A clinicopathologic study of folliculosebaceous cystic hamartoma. Am J Dermatopathol (2010) 1.00
Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin. J Dermatol (2010) 0.98
Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J Clin Endocrinol Metab (2004) 0.97
Case of anaphylaxis caused by ingestion of royal jelly. J Dermatol (2008) 0.96
Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocr J (2009) 0.94
Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats. Psychopharmacology (Berl) (2004) 0.92
Foot shock stress prolongs the telogen stage of the spontaneous hair cycle in a non-depilated mouse model. Exp Dermatol (2007) 0.92
[A case of eperisone hydrochloride (myonal)--induced drug eruption leading to erythema and angioedema]. Arerugi (2007) 0.91
420 nm intense continuous light therapy for acne. J Cosmet Laser Ther (2004) 0.91
Creeping eruption caused by a larva of the suborder Spirurina type X. Eur J Dermatol (2003) 0.91
Ultrastructural changes elicited by a non-ablative wrinkle reduction laser. Lasers Surg Med (2003) 0.90
Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model. J Mol Histol (2004) 0.89
Metastatic silicone granuloma: lupus miliaris disseminatus faciei-like facial nodules and sicca complex in a silicone breast implant recipient. Arch Dermatol (2002) 0.88
Functional polymorphisms in the mineralocorticoid receptor and amirolide-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism. Hum Genet (2002) 0.87
Genetic suppression of ghrelin receptors activates brown adipocyte function and decreases fat storage in rats. Regul Pept (2009) 0.87
Poroid hidradenoma: a case report with review of Japanese published work. J Dermatol (2007) 0.87
Targeting of sebocytes by aminolevulinic acid-dependent photosensitization. Photochem Photobiol (2006) 0.86
Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid. Int Arch Allergy Immunol (2005) 0.86
Expression of lumican in hidroacanthoma simplex and clonal-type seborrheic keratosis as a potent differential diagnostic marker. Am J Dermatopathol (2014) 0.86
Ghrelin suppresses noradrenaline release in the brown adipose tissue of rats. J Endocrinol (2009) 0.86
Lichen amyloidosis of the auricular concha: successful treatment with electrodesiccation. J Dermatol (2009) 0.85
Behçet's syndrome associated with acute myocardial infarction. J Nippon Med Sch (2003) 0.85
Histological hair removal study by ruby or alexandrite laser with comparative study on the effects of wavelength and fluence. J Cosmet Laser Ther (2004) 0.85
Prevalence of human papillomavirus DNA sequences in verrucous carcinoma of the lip: genomic and therapeutic approaches. Cancer Lett (2005) 0.84
Increased expression of miR-325-3p by urocortin 2 and its involvement in stress-induced suppression of LH secretion in rat pituitary. Am J Physiol Endocrinol Metab (2012) 0.84
Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus. Brain Res (2010) 0.84
Changes in cutaneous sensory nerve fibers induced by skin-scratching in mice. J Dermatol Sci (2007) 0.84
The relationship between serum levels of estradiol and osteoprotegerin in patients with anorexia nervosa. Endocr J (2007) 0.83
Basal cell carcinoma arising on a chronic lymphedematous leg. J Dermatol (2009) 0.83
Effect of chemical peeling on the skin in relation to UV irradiation. Exp Dermatol (2012) 0.83
Targeting of sebaceous glands by δ-aminolevulinic acid-based photodynamic therapy: An in vivo study. Lasers Surg Med (2011) 0.83
Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies. J Dermatol (2011) 0.83
A case of generalized argyria caused by the use of silver protein as a disinfection medicine. Acta Derm Venereol (2007) 0.83
Systemic immunotherapy with topical dinitrochlorobenzene as additional treatment of alopecia areata. Acta Derm Venereol (2002) 0.82
Vagus nerve stimulation induced long-lasting enhancement of synaptic transmission and decreased granule cell discharge in the hippocampal dentate gyrus of urethane-anesthetized rats. Brain Res (2012) 0.82
Papulonecrotic tuberculid with spontaneous remission. J Dermatol (2006) 0.82
Nitric oxide inhibits ultraviolet B-induced murine keratinocyte apoptosis by regulating apoptotic signaling cascades. Free Radic Res (2004) 0.82
Ultrastructural observations of chemical peeling for skin rejuvenation (ultrastructural changes of the skin due to chemical peeling). J Cosmet Laser Ther (2010) 0.81
Effect of chronic administration of a CRF(1) receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress. Eur J Pharmacol (2002) 0.81
Involvement of CRF2 receptor in the brain regions in restraint-induced anorexia. Neuroreport (2011) 0.81
Type 2 segmental manifestation of disseminated superficial actinic porokeratosis in a 7-year-old girl. Eur J Dermatol (2008) 0.80
Corticotropin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats. Exp Dermatol (2003) 0.80
Nicotine suppresses energy storage through activation of sympathetic outflow to brown adipose tissue via corticotropin-releasing factor type 1 receptor. Neurosci Lett (2009) 0.80
Corticotropin-releasing factor (CRF) receptor subtypes in mediating neuronal activation of brain areas involved in responses to intracerebroventricular CRF and stress in rats. Peptides (2011) 0.80
Extraskeletal osteochondroma arising on the plantar region. Case Rep Dermatol (2011) 0.80
Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma. J Invest Dermatol (2013) 0.80
Quantitative PCR of Propionibacterium acnes DNA in samples aspirated from sebaceous follicles on the normal skin of subjects with or without acne. J Med Dent Sci (2010) 0.80
Urocortin 2 induces tyrosine hydroxylase phosphorylation in PC12 cells. Biochem Biophys Res Commun (2005) 0.80
Effects of intracerebroventricular ghrelin on food intake and Fos expression in the arcuate nucleus of the hypothalamus in female rats vary with estrous cycle phase. Neurosci Lett (2013) 0.80
miR-449a contributes to glucocorticoid-induced CRF-R1 downregulation in the pituitary during stress. Mol Endocrinol (2013) 0.79
Lumican as a novel marker for differential diagnosis of Bowen disease and actinic keratosis. Am J Dermatopathol (2013) 0.79
Bowen's disease of the nail apparatus and association with various high-risk human papillomavirus types. J Dermatol Sci (2011) 0.79
Toxic epidermal necrolysis complicated by multiple intestinal ulcers. Int J Dermatol (2008) 0.79
Fractional CO2 laser for the treatment of acne scars. J Cosmet Dermatol (2011) 0.79
Clinical features of antinuclear antibody-positive patients with atopic dermatitis. J Nippon Med Sch (2009) 0.79
Case of Sweet's syndrome with extensive necrosis and ulcers accompanied by myelodysplastic syndrome. J Nippon Med Sch (2008) 0.79
Folliculosebaceous cystic hamartoma with hair shaft fragments. Eur J Dermatol (2005) 0.79
Case of multiple apocrine poroma in a patient without receiving radiation or chemotherapy. J Dermatol (2014) 0.78
Granulocyte adsorptive apheresis for leg ulcers complicated by rheumatoid arthritis: a report on three successfully treated cases. Int J Dermatol (2004) 0.78
Treatment for crusted scabies: limitations and side effects of treatment with ivermectin. J Nippon Med Sch (2014) 0.78
Histological evidence for skin rejuvenation using a combination of pneumatic energy, broadband light, and growth factor therapy. J Cosmet Laser Ther (2010) 0.78
Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors. BMC Cancer (2010) 0.78
Case of Merkel cell carcinoma with squamous cell carcinoma possibly arising in chronic radiodermatitis of the hand. J Dermatol (2014) 0.78
Ghrelin mRNA and GH secretagogue receptor mRNA in human GH-producing pituitary adenomas is affected by mutations in the alpha subunit of G protein. Clin Endocrinol (Oxf) (2003) 0.78
Sebaceous carcinoma of the nose with a regional metastasis following false-negative sentinel lymph node biopsy. Acta Derm Venereol (2011) 0.78
Clinicopathological significance of sentinel node biopsy in Japanese patients with cutaneous malignant melanoma. J Dermatol (2010) 0.78
Estrogens downregulate urocortin 2 expression in rat uterus. J Endocrinol (2013) 0.78
Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms. J Dermatol (2012) 0.78
Novel action of pituitary urocortin 2 in the regulation of expression and secretion of gonadotropins. J Endocrinol (2009) 0.78
Pemphigoid nodularis: two case studies and analysis of autoantibodies before and after the development of generalized blistering. J Nippon Med Sch (2005) 0.78
Atopic eczema complicated by systemic lupus erythematosus. Eur J Dermatol (2005) 0.78
[A case of human adjuvant's disease with various symptoms stimulating collagen diseases]. J Nippon Med Sch (2003) 0.78
Evaluation of hyperbaric oxygen therapy for chronic wounds. J Nippon Med Sch (2014) 0.78
Microinjection of different doses of corticotropin-releasing factor into the medial prefrontal cortex produces effects opposing anxiety-related behavior in rats. J Nippon Med Sch (2011) 0.77
Investigation by in vivo reflectance confocal microscopy: melanocytes at the edges of solar lentigines. Exp Dermatol (2012) 0.77
Light-emitting diode phototherapy at 630 +/- 3 nm increases local levels of skin-homing T-cells in human subjects. J Nippon Med Sch (2006) 0.77
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha. Eur J Dermatol (2007) 0.77
Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation. Neurol Med Chir (Tokyo) (2008) 0.77
Erratum to "changes in cutaneous sensory nerve fibers induced by skin-scratching in mice". J Dermatol Sci (2007) 0.77
Burns caused by dilute hydrofluoric acid in the bleach. J Nippon Med Sch (2002) 0.77
Role of urocortin 2 secreted by the pituitary in the stress-induced suppression of luteinizing hormone secretion in rats. Am J Physiol Endocrinol Metab (2010) 0.77
Clinical significance of blood coagulation factor XIII activity in adult Henoch-Schönlein purpura. J Nippon Med Sch (2013) 0.77
Dynamic changes in nerve growth factor and substance P in the murine hair cycle induced by depilation. J Dermatol (2006) 0.77
Distribution of urocortin 2 and urocortin 3 in rat brain. J Nippon Med Sch (2004) 0.77
Lichen aureus. Cutis (2002) 0.76
Successful use of heparin and warfarin in the treatment of cholesterol crystal embolization. J Dermatol (2008) 0.76